Financial Crunch Time For Inspiration As Hemophilia Pact With Ipsen Gets Surprise Revamp
Executive Summary
Inspiration Biopharma and hemophilia partner Ipsen have renegotiated their nearly three-year-old deal around two late-stage clinical assets. As part of the new deal, Ipsen has given up its option to buy Inspiration, providing the biotech with the opportunity – and the necessity – to find fresh financing from new backers in the coming months.